← Back to search

SCANTOX NEURO GMBH

GRAMBACH, 8074

UnclaimedClaim this profile (free)

Prime contracting experience

2 records from government sources. Past participation is not evidence of current teaming interest.

RoleAgencyDescriptionVehicleObligatedAction datePeriod
Prime
Department of Health and Human Services
National Institutes of Health
EXPERIMENTAL VALIDATION OF CANDIDATE ALZHEIMER'S DISEASE TREATMENTS IDENTIFIED BY MULTI-OMICS ANALYSES75N95022D00012USAspending$638,000Jun 3, 2026Jun 1, 2022 – May 31, 2023
Prime
Department of Health and Human Services
National Institutes of Health
EXPERIMENTAL VALIDATION OF CANDIDATE ALZHEIMER'S DISEASE TREATMENTS IDENTIFIED BY MULTI-OMICS ANALYSES.75N95022D00012USAspending$858,106Apr 30, 2025Jun 1, 2024 – Apr 30, 2025

Contract vehicles are shown only when present in the source record. Linked award numbers and vehicles open the authoritative record on USAspending.gov.

Agencies supported

  • Department of Health and Human ServicesGov-sourced

Government-sourced data comes from SAM.gov, SBA and USAspending.gov and is attributed to its source. Items marked company-reported were provided by the company and are verified by FedSub only where labeled. FedSub is a private company and is not affiliated with SBA, GSA/SAM.gov, or any government agency.

SCANTOX NEURO GMBH – Grambach | UEI ED41XCPBEPU1 | FedSub